aTyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) was the recipient of a large decline in short interest in the month of April. As of April 30th, there was short interest totalling 299,200 shares, a decline of 25.1% from the April 15th total of 399,500 shares. Based on an average daily volume of 560,900 shares, the […]